CHECKPOINT THERAPEUTICS INC's ticker is CKPT and the CUSIP is 162828107. A total of 23 filers reported holding CHECKPOINT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $120,000 | +6.2% | 115,152 | +4.3% | 0.00% | – |
Q2 2022 | $113,000 | -42.1% | 110,384 | 0.0% | 0.00% | – |
Q1 2022 | $195,000 | -45.5% | 110,384 | -4.0% | 0.00% | – |
Q4 2021 | $358,000 | -5.8% | 114,950 | 0.0% | 0.00% | – |
Q3 2021 | $380,000 | +8.6% | 114,950 | -3.1% | 0.00% | – |
Q2 2021 | $350,000 | -78.9% | 118,644 | -77.5% | 0.00% | – |
Q1 2021 | $1,656,000 | +11.1% | 527,523 | -6.2% | 0.00% | – |
Q4 2020 | $1,491,000 | +9.6% | 562,491 | +10.9% | 0.00% | – |
Q3 2020 | $1,360,000 | +34.7% | 507,161 | -0.6% | 0.00% | – |
Q2 2020 | $1,010,000 | +56.8% | 509,981 | +19.5% | 0.00% | – |
Q1 2020 | $644,000 | +33.6% | 426,786 | +52.3% | 0.00% | – |
Q4 2019 | $482,000 | -25.4% | 280,253 | +8.0% | 0.00% | – |
Q3 2019 | $646,000 | +249.2% | 259,598 | +325.2% | 0.00% | – |
Q2 2019 | $185,000 | +55.5% | 61,048 | +46.5% | 0.00% | – |
Q1 2019 | $119,000 | +56.6% | 41,674 | 0.0% | 0.00% | – |
Q4 2018 | $76,000 | -49.0% | 41,674 | 0.0% | 0.00% | – |
Q3 2018 | $149,000 | – | 41,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opus Point Partners Management, LLC | 112,760 | $281,000 | 0.51% |
PARK AVENUE SECURITIES LLC | 53,825 | $134,000 | 0.01% |
FENIMORE ASSET MANAGEMENT INC | 32,400 | $81,000 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 47,968 | $120,000 | 0.00% |
RHUMBLINE ADVISERS | 17,011 | $42,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1,122 | $2,794,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 298,542 | $743,000 | 0.00% |
BlackRock Inc. | 2,514,379 | $6,261,000 | 0.00% |
BB&T SECURITIES, LLC | 10,000 | $25,000 | 0.00% |
Bank of New York Mellon Corp | 64,094 | $159,000 | 0.00% |